Publication Provides Guidelines to Reduce Transportation Risks Associated with Neurosurgical Laser Ablation Multi-site Workflows
April 24, 2017 09:00 ET
|
MRI Interventions, Inc.
IRVINE, Calif., April 24, 2017 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) today announced that the reduced patient risk associated with a One-Room, One-Procedure workflow for laser...
MRI Interventions Announces Joint Development Agreement With Mayo Clinic for Development of MRI-Guided Stroke Therapies
April 20, 2017 09:00 ET
|
MRI Interventions, Inc.
IRVINE, Calif., April 20, 2017 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) today announced it has signed a joint development agreement with Mayo Clinic to design, develop and...
ClearPoint® Neuro Navigation System’s Real-time MRI Guided Platform to be Featured at AANS Practical Clinics for Fourth Consecutive Year
April 18, 2017 09:00 ET
|
MRI Interventions, Inc.
IRVINE, Calif., April 18, 2017 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) today announced that its ClearPoint® Neuro Navigation System will be featured in the laser ablation hands-on...
MRI Interventions Announces Record Quarterly Revenue, Record ClearPoint® System Procedures in 2017 First Quarter
April 06, 2017 09:00 ET
|
MRI Interventions, Inc.
IRVINE, Calif., April 06, 2017 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) today announced preliminary results for the quarter ended March 31, 2017. Total revenues were $2.0 million...
MRI Interventions, Inc. Announces 2016 Fourth Quarter and Full Year Results
February 28, 2017 16:05 ET
|
MRI Interventions, Inc.
Key 2016 accomplishments include year-over-year increases in revenue of 25%, ClearPoint® procedures of 32% and disposable product revenue of 36% IRVINE, Calif., Feb. 28, 2017 (GLOBE NEWSWIRE) --...
MRI Interventions, Inc. Fourth Quarter and Full Year 2016 Financial Results Conference Call and Webcast
February 21, 2017 16:05 ET
|
MRI Interventions, Inc.
IRVINE, Calif., Feb. 21, 2017 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) invites investors and analysts to participate in management’s broadcast review of the Company's 2016 fourth...
MRI Interventions, Inc. Announces Year-End Update, Including 2016 Fourth Quarter and Full Year Revenues
January 24, 2017 16:48 ET
|
MRI Interventions, Inc.
IRVINE, Calif., Jan. 24, 2017 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) today announced its preliminary revenues for the fourth quarter and the year ended December 31, 2016, and...
MRI Interventions’ ClearPoint® Surpasses Single-Year Milestone of 500 Procedures in 2016
January 04, 2017 09:00 ET
|
MRI Interventions, Inc.
IRVINE, Calif., Jan. 04, 2017 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) today announced that its ClearPoint® Neuro Navigation System was utilized in 500 minimally invasive brain...
MRI Interventions’ ClearPoint® Neuro Navigation System to be Utilized in Medicenna Therapeutics’ Phase 2 MDNA55 Clinical Trial for the Treatment of Recurrent Glioblastoma
December 19, 2016 09:00 ET
|
MRI Interventions, Inc.
IRVINE, Calif., Dec. 19, 2016 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) today announced that its ClearPoint® Neuro Navigation System will be utilized in a Phase 2 Trial for recurrent...
MRI Interventions’ ClearPoint® Neuro Navigation System Utilized in Voyager Therapeutics’ VY-AADC01 Phase 1b Trial; Positive Interim Results Reported
December 08, 2016 09:00 ET
|
MRI Interventions, Inc.
Interim data from Cohorts 1 and 2 demonstrated that accurate MRI-guided delivery of escalating doses of VY-AADC01 were well tolerated and resulted in increased coverage of the putamenClearPoint Neuro...